Preeclampsia and the COVID-19 pandemic
Article Sidebar
Main Article Content
Abstract
Objective: The novel coronavirus pandemic (COVID-19) has deteriorating effects on vulnerable populations, including pregnant women. Previous studies suggested increased adverse pregnancy outcomes like preeclampsia in this population, but the results are inconclusive. Therefore, this study evaluated the changes in adverse pregnancy outcomes, primarily preeclampsia, among pregnant women in the Black Sea region in Turkey.
Material and Methods: This study included all deliveries between April 1st, 2018, and December 31st, 2019, as the pre-pandemic cohort and between April 1st, 2020, and December 31st, 2021, as the pandemic cohort. The primary objective of the study was to compare the preeclampsia rates.
Results: A total of 4379 patients were included, 2000 in pre-pandemic and 2379 in pandemic cohorts. The preeclampsia rate in the pre-pandemic cohort (11.0%) was similar to the pandemic cohort (9.7%) (p=0.16), likewise, the mean baby weights were also similar between cohorts (p=0.32).
Conclusion: The preeclampsia rates in the pre-pandemic period did not change significantly during the pandemic. However, this was based on observational data, which needs further evaluation and confirmation in controlled studies.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-02-12
Published 2023-02-15
References
Rana, S., E. Lemoine, J.P. Granger, et al., Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res, 2019. 124(7): p. 1094-1112.
Jung, E., R. Romero, L. Yeo, et al., The etiology of preeclampsia. Am J Obstet Gynecol, 2022. 226(2S): p. S844-S866.
Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol, 2013. 122(5): p. 1122-1131.
ACOG Practice Bulletin No. 202 Summary: Gestational Hypertension and Preeclampsia. Obstet Gynecol, 2019. 133(1): p. 1.
Ives, C.W., R. Sinkey, I. Rajapreyar, et al., Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol, 2020. 76(14): p. 1690-1702.
Papageorghiou, A.T., P. Deruelle, R.B. Gunier, et al., Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol, 2021. 225(3): p. 289 e1-289 e17.
Otifi, H.M. and B.K. Adiga, Endothelial Dysfunction in Covid-19 Infection. Am J Med Sci, 2022. 363(4): p. 281-287.
World Health Organization. Coronavirus (COVID-19) Dashboard. 2022 (Accessed: October 5th, 2022); Available from: https://covid19.who.int.
Schwartz, D.A. and A.L. Graham, Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses, 2020. 12(2).
Favre, G., L. Pomar, D. Musso, et al., 2019-nCoV epidemic: what about pregnancies? Lancet, 2020. 395(10224): p. e40.
Wang, C.L., Y.Y. Liu, C.H. Wu, et al., Impact of COVID-19 on Pregnancy. Int J Med Sci, 2021. 18(3): p. 763-767.
Moore, K.M. and M.S. Suthar, Comprehensive analysis of COVID-19 during pregnancy. Biochem Biophys Res Commun, 2021. 538: p. 180-186.
Mendoza, M., I. Garcia-Ruiz, N. Maiz, et al., Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG, 2020. 127(11): p. 1374-1380.
Rolnik, D.L., Can COVID-19 in pregnancy cause preeclampsia? BJOG, 2020. 127(11): p. 1381.
Wei, S.Q., M. Bilodeau-Bertrand, S. Liu, et al., The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ, 2021. 193(16): p. E540-E548.
Jamieson, D.J. and S.A. Rasmussen, An update on COVID-19 and pregnancy. Am J Obstet Gynecol, 2022. 226(2): p. 177-186.